Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Nicole Baumer to Down Syndrome

This is a "connection" page, showing publications Nicole Baumer has written about Down Syndrome.

 
Connection Strength
  
 
 
10.009
  
  1. Patel LR, O'Neill M, Anzueto G, Olsen D, Pawlowski K, Santoro JD, Sideridis G, Spinazzi N, Baumer NT. Neurobehavioural Patterns in the Diagnosis of Autism Spectrum Disorder in Down Syndrome. J Intellect Disabil Res. 2025 09; 69(9):809-821.
    View in: PubMed
    Score: 0.550
  2. La Valle C, Mejia GD, Wilkinson CL, Baumer N. Examining Concurrent Associations Between Gesture Use, Developmental Domains, and Autistic Traits in Toddlers With Down Syndrome. J Speech Lang Hear Res. 2025 03 05; 68(3):1126-1136.
    View in: PubMed
    Score: 0.532
  3. Baumer N, DePillis R, Pawlowski K, Zhang B, Mazumdar M. Developmental Milestones for Children With Down Syndrome. Pediatrics. 2024 Oct 01; 154(4).
    View in: PubMed
    Score: 0.521
  4. Engelstad AM, Joffe-Nelson L, Hurewitz SR, Pawlowski KG, Baumer NT. The JASPER (Joint Attention, Symbolic Play, Engagement and Regulation) Intervention in Down Syndrome: A pilot study. Res Dev Disabil. 2024 Sep; 152:104796.
    View in: PubMed
    Score: 0.514
  5. Weas S, Pawlowski K, Miller M, DePillis R, Baumer N. Psychotropic Medication Prescription Patterns in Down Syndrome in a Large Pediatric Specialty Clinic. J Child Adolesc Psychopharmacol. 2025 May; 35(4):249-254.
    View in: PubMed
    Score: 0.512
  6. Reynders SS, Lombardo AM, Davidson EJ, Guan JL, Pawlowski KG, Simons NZ, Baumer NT. 15 Years of Inclusive Employment in a Down Syndrome Clinic. Work. 2024; 79(3):1517-1523.
    View in: PubMed
    Score: 0.494
  7. Spellun A, Harstad E, Hojlo M, Milliken A, Pawlowski K, Sideridis G, Baumer N. Cross-Sectional Analysis of Caregiver-Reported Expressive Language Profiles and Associated Covariates in Individuals with Down Syndrome. J Dev Behav Pediatr. 2024 01 01; 45(1):e63-e71.
    View in: PubMed
    Score: 0.493
  8. Baumer NT, Hojlo MA, Pawlowski KG, Milliken AL, Lombardo AM, Sargado S, Soccorso C, Davidson EJ, Barbaresi WJ. Co-occurring conditions in Down syndrome: Findings from a clinical database. Am J Med Genet C Semin Med Genet. 2023 12; 193(4):e32072.
    View in: PubMed
    Score: 0.488
  9. Baumer NT, Capone G. Psychopharmacological treatments in Down syndrome and autism spectrum disorder: State of the research and practical considerations. Am J Med Genet C Semin Med Genet. 2023 12; 193(4):e32069.
    View in: PubMed
    Score: 0.488
  10. Soccorso C, Milliken A, Hojlo M, Pawlowski K, Weas S, Sideridis G, Baumer N. Quality of Life and Family Impact in Down Syndrome, Autism Spectrum Disorder, and Co-occurring Down Syndrome and Autism Spectrum Disorder. J Dev Behav Pediatr. 2023 04 01; 44(3):e185-e195.
    View in: PubMed
    Score: 0.469
  11. Spinazzi NA, Santoro JD, Pawlowski K, Anzueto G, Howe YJ, Patel LR, Baumer NT. Co-occurring conditions in children with Down syndrome and autism: a retrospective study. J Neurodev Disord. 2023 03 02; 15(1):9.
    View in: PubMed
    Score: 0.466
  12. Baumer NT, Hojlo MA, Lombardo AM, Milliken AL, Pawlowski KG, Sargado S, Soccorso C, Davidson EJ, Barbaresi WJ. Development and implementation of a longitudinal clinical database for down syndrome in a large pediatric specialty clinic: Methodology and feasibility. J Intellect Disabil. 2024 Mar; 28(1):196-215.
    View in: PubMed
    Score: 0.454
  13. Stredny CM, Hauptman AJ, Sargado S, Soccorso C, Katz T, Gorman MP, Baumer NT. Development of a multidisciplinary clinical approach for unexplained regression in Down syndrome. Am J Med Genet A. 2022 08; 188(8):2509-2511.
    View in: PubMed
    Score: 0.444
  14. Sargado S, Milliken AL, Hojlo MA, Pawlowski KG, Deister D, Soccorso CN, Baumer NT. Is Developmental Regression in Down Syndrome Linked to Life Stressors? J Dev Behav Pediatr. 2022 09 01; 43(7):427-436.
    View in: PubMed
    Score: 0.443
  15. Baumer NT, Becker ML, Capone GT, Egan K, Fortea J, Handen BL, Head E, Hendrix JE, Litovsky RY, Strydom A, Tapia IE, Rafii MS. Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group. J Neurodev Disord. 2022 03 23; 14(1):22.
    View in: PubMed
    Score: 0.437
  16. Christensen KM, Hojlo M, Milliken A, Baumer NT. Parent Attitudes Toward Enhancing Cognition and Clinical Research Trials in Down Syndrome: A Mixed Methods Study. J Dev Behav Pediatr. 2021 Jun-Jul 01; 42(5):380-388.
    View in: PubMed
    Score: 0.413
  17. Baumer N, Davidson EJ. Supporting a happy, healthy adolescence for young people with Down syndrome and other intellectual disabilities: recommendations for clinicians. Curr Opin Pediatr. 2014 Aug; 26(4):428-34.
    View in: PubMed
    Score: 0.257
  18. Sutter EN, Collimore-Doherty AN, Wilkerson E, Baumer N, Iverson JM. Developmental Trajectories of Locomotor Skills in Infants With Down Syndrome. Pediatr Phys Ther. 2026 Jul 01; 38(3):348-355.
    View in: PubMed
    Score: 0.147
  19. Jones JT, Talib N, Cramer E, Valentini D, Baumer N, Sargado S, Oreskovic NM, Santoro SL, Krell K, Santoro JD, Vellody K, McCormick A, Franklin C, Kishnani P, Hart S, Spiridigliozzi G, Kitchen J, Skotko BG. The Detection of Down Syndrome Arthritis in Clinical Practice: A Multicenter, International Pilot and Feasibility Study of a Down Syndrome-Specific Musculoskeletal Screening Tool. Am J Med Genet A. 2026 03; 200(3):653-660.
    View in: PubMed
    Score: 0.140
  20. La Valle C, Hurewitz S, Geiger M, Pawlowski K, Baumer N, Wilkinson CL. Concurrent validity in language and motor domains on the Vineland-3 and Mullen Scales of Early Learning in young children with Down syndrome. Res Dev Disabil. 2025 Apr; 159:104966.
    View in: PubMed
    Score: 0.134
  21. Geiger M, Hurewitz SR, Pawlowski K, Baumer NT, Wilkinson CL. Alterations in aperiodic and periodic EEG activity in young children with Down syndrome. Neurobiol Dis. 2024 10 01; 200:106643.
    View in: PubMed
    Score: 0.129
  22. Santoro JD, Khoshnood MM, Jafarpour S, Nguyen L, Boyd NK, Vogel BN, Kammeyer R, Patel L, Manning MA, Rachubinski AL, Filipink RA, Baumer NT, Santoro SL, Franklin C, Tamrazi B, Yeom KW, Worley G, Espinosa JM, Rafii MS. Neuroimaging abnormalities associated with immunotherapy responsiveness in Down syndrome regression disorder. Ann Clin Transl Neurol. 2024 04; 11(4):1034-1045.
    View in: PubMed
    Score: 0.125
  23. Sharma A, Baumer N, Augustyn M. Hyperphagia and Down Syndrome. J Dev Behav Pediatr. 2023 08 01; 44(6):e444-e446.
    View in: PubMed
    Score: 0.119
  24. Santoro JD, Filipink RA, Baumer NT, Bulova PD, Handen BL. Down syndrome regression disorder: updates and therapeutic advances. Curr Opin Psychiatry. 2023 03 01; 36(2):96-103.
    View in: PubMed
    Score: 0.115
  25. Oreskovic NM, Baumer NT, Di Camillo C, Cornachia M, Franklin C, Hart SJ, Kishnani PS, McCormick A, Milliken AL, Patsiogiannis V, Pawlowski KG, Santoro SL, Sargado S, Scoppola V, Torres A, Valentini D, Vellody K, Villani A, Skotko BG. Cardiometabolic profiles in children and adults with overweight and obesity and down syndrome. Am J Med Genet A. 2023 03; 191(3):813-822.
    View in: PubMed
    Score: 0.115
  26. Hojlo MA, Milliken AL, Baumer NT, Davidson EJ. DSFit: a feasibility pilot study of a group exercise programme for adolescents with Down syndrome. J Intellect Disabil Res. 2022 12; 66(12):952-966.
    View in: PubMed
    Score: 0.113
  27. Pinku H, Hüls A, Feany PT, Baumer N, Dierssen M, Bargagna S, Costa AC, Chicoine BA, Rebillat AS, Sgandurra G, Valentini D, Rohrer RT, Levin J, Lakhanpaul M, Carfì A, Sherman SL, Strydom A, Ghosh S. Differences in clinical presentation, severity, and treatment of COVID-19 among individuals with Down syndrome from India and high-income countries: Data from the Trisomy 21 Research Society survey. J Glob Health. 2022 Aug 08; 12:05035.
    View in: PubMed
    Score: 0.112
  28. Santoro SL, Baumer NT, Cornacchia M, Franklin C, Hart SJ, Haugen K, Hojlo MA, Horick N, Kishnani PS, Krell K, McCormick A, Milliken AL, Oreskovic NM, Pawlowski KG, Sargado S, Torres A, Valentini D, Vellody K, Skotko BG. Unexplained regression in Down syndrome: Management of 51 patients in an international patient database. Am J Med Genet A. 2022 10; 188(10):3049-3062.
    View in: PubMed
    Score: 0.112
  29. McCann B, Levman J, Baumer N, Lam MY, Shiohama T, Cogger L, MacDonald A, Ijner P, Takahashi E. Structural magnetic resonance imaging demonstrates volumetric brain abnormalities in down syndrome: Newborns to young adults. Neuroimage Clin. 2021; 32:102815.
    View in: PubMed
    Score: 0.105
  30. Levman J, MacDonald A, Baumer N, MacDonald P, Stewart N, Lim A, Cogger L, Shiohama T, Takahashi E. Structural magnetic resonance imaging demonstrates abnormal cortical thickness in Down syndrome: Newborns to young adults. Neuroimage Clin. 2019; 23:101874.
    View in: PubMed
    Score: 0.090
  31. Shiohama T, Levman J, Baumer N, Takahashi E. Structural Magnetic Resonance Imaging-Based Brain Morphology Study in Infants and Toddlers With Down Syndrome: The Effect of Comorbidities. Pediatr Neurol. 2019 11; 100:67-73.
    View in: PubMed
    Score: 0.089
  32. Trowbridge SK, Yuskaitis CJ, Baumer N, Libenson M, Prabhu SP, Harini C. Brain MRI abnormalities in patients with infantile spasms and Down syndrome. Epilepsy Behav. 2019 03; 92:57-60.
    View in: PubMed
    Score: 0.087
  33. Hart SJ, Visootsak J, Tamburri P, Phuong P, Baumer N, Hernandez MC, Skotko BG, Ochoa-Lubinoff C, Liogier D'Ardhuy X, Kishnani PS, Spiridigliozzi GA. Pharmacological interventions to improve cognition and adaptive functioning in Down syndrome: Strides to date. Am J Med Genet A. 2017 Nov; 173(11):3029-3041.
    View in: PubMed
    Score: 0.080
  34. Lavigne J, Sharr C, Elsharkawi I, Ozonoff A, Baumer N, Brasington C, Cannon S, Crissman B, Davidson E, Florez JC, Kishnani P, Lombardo A, Lyerly J, McDonough ME, Schwartz A, Berrier K, Sparks S, Stock-Guild K, Toler TL, Vellody K, Voelz L, Skotko BG. Thyroid dysfunction in patients with Down syndrome: Results from a multi-institutional registry study. Am J Med Genet A. 2017 Jun; 173(6):1539-1545.
    View in: PubMed
    Score: 0.077
  35. Sharr C, Lavigne J, Elsharkawi IM, Ozonoff A, Baumer N, Brasington C, Cannon S, Crissman B, Davidson E, Florez JC, Kishnani P, Lombardo A, Lyerly J, McDonough ME, Schwartz A, Berrier KL, Sparks S, Stock-Guild K, Toler TL, Vellody K, Voelz L, Skotko BG. Detecting celiac disease in patients with Down syndrome. Am J Med Genet A. 2016 12; 170(12):3098-3105.
    View in: PubMed
    Score: 0.074
  36. Lavigne J, Sharr C, Ozonoff A, Prock LA, Baumer N, Brasington C, Cannon S, Crissman B, Davidson E, Florez JC, Kishnani P, Lombardo A, Lyerly J, McCannon JB, McDonough ME, Schwartz A, Berrier KL, Sparks S, Stock-Guild K, Toler TL, Vellody K, Voelz L, Skotko BG. National down syndrome patient database: Insights from the development of a multi-center registry study. Am J Med Genet A. 2015 Nov; 167A(11):2520-6.
    View in: PubMed
    Score: 0.069
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)